Why the study?
Does catheter-based renal denervation reduce office blood pressure in patients with resistant hypertension compared to a sham procedure?
Population
Patients with resistant hypertension (discussing the Symplicity HTN-3 trial population)
Comparison
Catheter-based renal denervation vs Sham procedure
Design
Editorial
Authors
Loading...
Neutral Symplicity HTN-3 result advises against routine renal denervation adoption; leaves open optimization of technique, devices, and patient selection.
Does catheter-based renal denervation reduce office blood pressure in patients with resistant hypertension compared to a sham procedure?
Following the neutral results of Symplicity HTN-3, future research on renal denervation must address procedural adequacy, device differences, patient selection, and medication adherence.
Blankestijn et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: